Trials / Conditions / Prostatic Adenocarcinoma

Prostatic Adenocarcinoma

7 registered clinical trials studyying Prostatic Adenocarcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivat NCT06015321	Samsung Medical Center	Phase 2
Recruiting	Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermedia NCT05498272	Rana McKay, MD	Phase 2
Completed	Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics o NCT04063800	University Hospital, Brest	—
Completed	Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Mi NCT03384199	Kasr El Aini Hospital	Phase 2
Completed	Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid NCT02361515	Hospices Civils de Lyon	N/A
Completed	Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Canc NCT01542021	Memorial Sloan Kettering Cancer Center	N/A
Completed	Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer NCT01431391	Dendreon	Phase 2